Compass Minerals International (CMP) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
6 Feb, 2026Executive summary
Net income reached $18.6 million in Q1 2026, reversing a net loss of $23.6 million in the prior year, with diluted EPS of $0.43 compared to a loss of $0.57.
Adjusted EBITDA rose 103% year-over-year to $65.3 million, driven by strong salt business, improved Plant Nutrition performance, and cost structure improvements.
Leverage ratio improved to 3.6x from 5.3x year-over-year, with net debt reduced by 10% to $836.9 million.
Full-year adjusted EBITDA guidance raised by 2% at the midpoint to $208–$240 million.
Salt and Plant Nutrition segments both saw higher operating earnings and margins due to volume growth, pricing, and cost improvements.
Financial highlights
Revenue rose 29% year-over-year to $396.1 million, with Salt segment revenue up 37% to $331.5 million and Plant Nutrition revenue at $60.8 million.
Operating income increased to $36.6 million from $0.5 million a year ago, mainly due to Salt segment growth.
Adjusted EBITDA margin improved to 16.5%, with Salt segment at 20.3% and Plant Nutrition at 21.1%.
Cash and cash equivalents were $46.7 million at quarter-end, with total liquidity of $341.7 million including available credit.
Net cash used in operating activities was $37.0 million, reflecting seasonal working capital and tax settlement.
Outlook and guidance
Full-year 2026 adjusted EBITDA guidance raised to $208–$240 million, with Salt segment at $230–$252 million and Plant Nutrition at $34–$39 million.
Capital expenditures for 2026 forecasted at $90–$110 million.
Effective tax rate guidance for 2026 is 30–34%.
Guidance reflects strong salt demand, improved Plant Nutrition margins, and impact of Wynyard SOP sale.
The company expects to meet liquidity needs over the next 12 months through cash flow and available credit.
Latest events from Compass Minerals International
- All voting items passed and no stockholder questions were raised during the meeting.CMP
AGM 20266 Mar 2026 - Shareholders will vote on directors, executive pay, and auditor, with a focus on governance and ESG.CMP
Proxy Filing23 Jan 2026 - Key votes include director elections, executive pay, and auditor ratification for 2026.CMP
Proxy Filing23 Jan 2026 - 2024 net loss from impairments; 2025 outlook sees Salt volume growth and stable capex.CMP
Q4 202411 Jan 2026 - Q1 FY2025 revenue down 10%, net loss narrowed, and Plant Nutrition volumes rose.CMP
Q1 202516 Dec 2025 - Net loss narrowed, debt fell, and 2026 guidance targets margin and EBITDA growth.CMP
Q4 20259 Dec 2025 - Proxy covers director elections, executive pay, incentive plan amendment, auditor ratification, and ESG goals.CMP
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, executive pay, incentive plan, and auditor ratification.CMP
Proxy Filing1 Dec 2025 - Corrected auditor fees show KPMG received $3.8M in 2024, with prior years restated.CMP
Proxy Filing1 Dec 2025